#Endovascular Stent Graft Market Growth

[willyskristina]

Aortic Stents Grafts Market

Aortic Stents Grafts Market Size, Share, Trends: Medtronic plc Leads

Increasing Adoption of Fenestrated and Branched Stent Grafts

Market Overview:

The global Aortic Stents Grafts Market is projected to grow at a CAGR of 7.2% from 2024 to 2031. The market value is expected to rise from XX USD in 2024 to YY USD by 2031. North America currently dominates the market, with key metrics indicating a growing demand for minimally invasive aortic aneurysm treatments. The market is experiencing significant growth due to increasing prevalence of aortic aneurysms, technological advancements in stent graft designs, and rising adoption of endovascular procedures. 

DOWNLOAD FREE SAMPLE

Market Trends:

The aortic stent grafts industry is seeing a considerable shift towards the use of fenestrated and branching stent grafts. These advanced devices are intended to treat difficult aortic aneurysms, particularly those that affect the renal and visceral arteries. The necessity for more physically complex situations and a desire to broaden the applicability of endovascular aneurysm repair (EVAR) are driving this trend. Fenestrated and branching stent grafts have been proven in studies to successfully treat up to 85% of juxtarenal aneurysms that were previously unsuitable for routine EVAR, resulting in a 30% reduction in open surgical operations for complicated aortic aneurysms.

Market Segmentation:

Abdominal Aortic Stent Grafts have the biggest market share in the aortic stent grafts business, owing to the higher prevalence of abdominal aortic aneurysms (AAA) compared to thoracic aneurysms. This segment's dominance is related to the extensive use of endovascular aneurysm repair (EVAR) procedures for AAA therapy, as well as continuing technological advancements in stent graft design. Recent advances in abdominal aortic stent grafts have centred on increasing long-term durability and anatomical application. For example, the introduction of low-profile delivery devices has allowed for the treatment of patients with smaller access channels, potentially boosting the eligible patient group by 30%. Furthermore, next generation stent grafts with active fixation mechanisms have demonstrated a 50% reduction in type I endoleaks, a typical consequence of EVAR, resulting in better long-term results.

The hospital segment of the abdominal aortic stent grafts market has experienced particularly rapid expansion. With the growing complexity of EVAR procedures and the necessity for specialised imaging equipment, hospitals continue to be the principal site for these interventions. According to studies, high-volume hospital centres that execute more than 50 EVAR procedures per year had 25% lower death rates than low-volume centres, leading to the centralisation of these treatments in specialised institutions. This tendency has resulted in large expenditures in hybrid operating rooms capable of performing advanced endovascular operations, reinforcing the hospital segment's market dominance.

Market Key Players:

Medtronic plc

Cook Medical

W. L. Gore & Associates

Terumo Corporation

Cardinal Health (Cordis)

Endologix LLC

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[credenceresearchdotblog]

The Vascular Grafts Market is projected to grow from USD 1,263.48 million in 2023 to an estimated USD 2,422.39 million by 2032, with a compound annual growth rate (CAGR) of 7.50% from 2024 to 2032. The global vascular grafts market has seen significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the aging population, and advancements in medical technology. Vascular grafts are used in surgical procedures to bypass, repair, or replace damaged blood vessels, making them a crucial component in the treatment of various vascular conditions. These grafts can be synthetic, biological, or composite, depending on the material used, and they play a critical role in procedures such as coronary artery bypass surgery, peripheral artery disease treatment, and hemodialysis access.

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

Market Overview

As of 2024, the vascular grafts market is experiencing a robust growth trajectory, with a market value that is expected to reach billions of dollars in the coming years. The demand for vascular grafts is fueled by the increasing burden of cardiovascular diseases, which are among the leading causes of death globally. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) claim over 17 million lives annually, and this number is expected to rise due to factors such as unhealthy lifestyles, rising obesity rates, and an aging population.

The market is segmented based on product type, application, and end-user. The main types of vascular grafts include:

1. Endovascular Stent Grafts – Used in minimally invasive procedures to treat aneurysms or occluded blood vessels. 2. Peripheral Vascular Grafts – Typically used to bypass or replace damaged vessels in the peripheral arterial system. 3. Hemodialysis Access Grafts – Commonly used to create arteriovenous (AV) fistulas for patients undergoing dialysis.

Key Drivers of Market Growth

1. Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is the primary driver of the vascular grafts market. As lifestyles become more sedentary, coupled with poor dietary habits and rising levels of obesity, the demand for cardiovascular procedures such as coronary artery bypass grafting (CABG) is rising.

2. Aging Population The global population is aging, and older adults are more prone to cardiovascular diseases, atherosclerosis, and related complications. This demographic trend is a major factor contributing to the growth of the vascular grafts market. Elderly individuals often require vascular grafts in procedures such as aneurysm repair or dialysis access creation, which boosts demand.

3. Technological Advancements The development of new materials and technologies for vascular grafts has significantly enhanced their performance and outcomes. For instance, the introduction of bioengineered grafts and hybrid materials that combine synthetic and biological properties has improved the compatibility and durability of grafts. Furthermore, advancements in endovascular procedures, which are less invasive than traditional open surgeries, have driven the adoption of vascular grafts, particularly stent grafts.

4. Increasing Incidence of End-Stage Renal Disease (ESRD) The rising prevalence of diabetes and hypertension has contributed to a growing number of patients with end-stage renal disease (ESRD). These patients require hemodialysis, and vascular grafts are often used to create AV fistulas for dialysis access. As the incidence of ESRD increases, so does the demand for vascular grafts, particularly in the healthcare sector of developed countries.

Challenges Facing the Market

Despite the promising growth, the vascular grafts market faces several challenges. One major concern is the risk of graft failure due to infection, thrombosis, or rejection. While advances in material science have improved the performance of grafts, complications still arise, particularly in high-risk patients. Additionally, the cost of vascular grafts and associated procedures can be prohibitive for patients in low- and middle-income countries, limiting access to these life-saving interventions.

Another challenge is the stringent regulatory environment that governs the approval and commercialization of vascular grafts. Medical devices, especially those used in critical procedures, are subject to rigorous testing and approval processes. This can delay the introduction of new products to the market.

Regional Insights

The vascular grafts market is segmented by region, with North America, Europe, Asia-Pacific, and the Rest of the World (RoW) being key markets. North America holds the largest share of the market, driven by the high prevalence of cardiovascular diseases, a well-established healthcare system, and the presence of leading medical device manufacturers. Europe follows closely behind, with a similar disease burden and strong healthcare infrastructure.

In contrast, the Asia-Pacific region is expected to witness the fastest growth in the coming years, driven by the increasing healthcare expenditure, a growing middle class, and rising awareness of cardiovascular health. Countries such as China and India are seeing a surge in demand for vascular grafts due to the rising incidence of lifestyle-related diseases and improvements in healthcare accessibility.

Future Outlook

The future of the vascular grafts market looks promising, with continued growth expected due to ongoing advancements in medical technology, an aging population, and the increasing prevalence of cardiovascular diseases. Innovations in graft materials, such as the use of bioresorbable polymers and tissue-engineered grafts, will likely enhance the durability and success rates of vascular procedures.

Moreover, as healthcare systems in emerging economies improve, the demand for vascular grafts in these regions is expected to increase. Government initiatives aimed at improving cardiovascular health and expanding access to healthcare services will also play a crucial role in driving market growth.

Key players

Medtronic

Terumo Corporation

LeMaitre Vascular, Inc.

Getinge AB

BD (Becton Dickinson)

Abbott

Braun Melsungen AG

L. Gore and Associates, Inc.

MicroPort Scientific Corporation

Endologix

Segments

Based on product

Haemodialysis Access Grafts

Endovascular Stent Grafts

Coronary Artery Based on-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Based on application

Cardiac Aneurysm

Endovascular Stent Graft

Vascular Graft

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Others

Based on raw material

Synthetic Vascular Grafts

Polytetrafluoroethylene (PTFE) Grafts

Polyester Grafts,

Polyurethane Grafts

Biological Vascular Grafts

Autografts

Allografts

Xenografts

Hybrid Vascular Grafts

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[healthcareruhi]

Vascular Guidewires Market Analysis, Share, Growth rate and Market Forecasts to 2030

The Global Vascular Guidewires Market was valued at US$ 981 Mn in 2022, estimated to reach US$ 1,791 Mn by 2030, with a CAGR of 7.69% from 2023-2030. A guidewire is a flexible wire that, in some circumstances, may also be a spring. It aids surgeons in the introduction and accurate positioning of a medical device, notably a prosthesis, within a patient's body. During an interventional procedure, the use of guidewires is crucial since they help a doctor and direct a medical instrument through the patient's anatomy. 

A guidewire completes the role of a guide towards the insertion of larger devices, such as a catheter, into the patient's body. The material majorly used in making guidewire is core steel with a covering applied over the core steel. The coating may be of hydrophilic or hydrophobic polymer. The vascular guidewires are used for the numerous surgical procedures such as angioplasty stents, angioplasty balloons, endovascular aneurysm repair stent grafts, hemodynamic flow alteration devices, and others.

Market Segmentation The scope of the Global Vascular Guidewires Market covers segmentation based on Application, Coating Type, End User, and Region. Based on Application, the market is segmented into Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires. Based on Coating Type, the market is divided into Coated and Non-Coated. Based on End Users, the market is classified into Hospitals and Ambulatory Surgical Centers. Request A Free Sample@

Regional Analysis The Global Vascular Guidewires Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Key Players Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company (C.R. Bard), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Olympus Corporation, and Terumo Corporation.

Key Questions Addressed by the Report • What are the Key Opportunities in Global Bonsai Market?   • What will be the growth rate from 2023 to 2030?   • Which segment/region will have the highest growth?   • What are the factors that will impact/drive the Market?   • What is the competitive Landscape in the Industry?

About Us:

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.

QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.

QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.

Contact Us:

     6060 N Central Expy #500 TX 75204, U.S.A

     sales@qualiketresearch.com

     +1 214 660 5449

     1201, City Avenue, Shankar Kalat Nagar,

     Wakad, Pune 411057, Maharashtra, India

     sales@qualiketresearch.com

     +91 9284752585

     Sharjah Media City , Al Messaned, Sharjah, UAE.

     sales@qualiketresearch.com

     +91 9284752585

[pranalipawarshinde]

Vascular Grafts Market growth, business opportunities, share value, key insights and size estimation by 2031 | erumo Medical Corporation, and W. L. Gore & Associates, Inc

Global Vascular Grafts Market report from Global Insight Services is the single authoritative source of intelligence on Vascular Grafts Market . The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS21376

A vascular graft is a surgical procedure in which a section of a healthy blood vessel is removed from one area of the body and transplanted to another area to replace a damaged or diseased blood vessel. The most common type of vascular graft is an arterial graft, which is used to replace a damaged or diseased artery. Arterial grafts can be made from a variety of different materials, including synthetic materials, such as Dacron, or natural materials, such as veins or arteries from another part of the body. Vascular grafts are also used to create new blood vessels, such as when a bypass graft is used to create a new route around a blockage in an artery.

Key Trends

There are a few key trends in vascular graft technology.

One is the development of new materials that can be used for grafts. This includes things like using synthetic materials or using biodegradable materials.

Another trend is the development of new methods for making grafts. This includes using 3D printing or using nanotechnology.

Finally, there is a trend toward developing new methods for attaching grafts to the body. This includes using things like adhesive tape or staples.

Key Drivers

There are several key drivers of the vascular graft market.

The first is the aging population. As people age, they are more likely to develop diseases that require vascular surgery, such as atherosclerosis.

The second driver is the increasing prevalence of obesity and diabetes. These conditions increase the risk of developing vascular disease.

The third driver is the improving technology of vascular grafts. This has led to better outcomes for patients and increased demand for these products.

Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS21376

Restraints & Challenges

The key restraints and challenges in the vascular grafts market include the lack of availability of suitable donors, the high cost of the procedures, and the risk of complications associated with the procedures.

Market Segments

The Vascular Grafts Market is segmented by product, raw material, and end users. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm and thoracic aortic aneurysm. By raw material, it is categorized in polyester, polytetrafluoroethylene, polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Vascular Grafts Market includes players such as  B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.

Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS21376

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

New Report Published by Global Insight Services –https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

[marketsizereports]

Emerging Technologies and Innovations in the North America Aortic and Vascular Graft Procedures Market

The North America Aortic and Vascular Graft Procedures market has been witnessing significant advancements in technology and innovation. These emerging technologies are aimed at improving patient outcomes, reducing complications, and enhancing the overall efficacy of aortic and vascular graft procedures. Here are some notable innovations in this field:

Endovascular Aneurysm Repair (EVAR): EVAR is a minimally invasive procedure used to treat abdominal aortic aneurysms (AAAs). It involves the placement of a stent graft within the aorta to reinforce the weakened vessel walls and prevent aneurysm rupture. EVAR has gained popularity due to its reduced invasiveness, shorter recovery times, and lower mortality rates compared to open surgical repair.

Fenestrated and Branched Endovascular Aortic Repair (FEVAR and BEVAR): FEVAR and BEVAR are advanced techniques used to treat complex aortic aneurysms that involve the renal arteries or other branch vessels. These procedures utilize custom-made stent grafts with fenestrations or branches that align with the patient's specific anatomy, allowing for precise deployment and preservation of blood flow to vital organs.

Bioactive and Biodegradable Grafts: Bioactive grafts are designed to stimulate tissue regeneration and promote healing. They may incorporate growth factors or coatings that encourage the body's natural healing processes, leading to better integration of the graft and reduced risk of complications. Biodegradable grafts are gradually absorbed by the body over time, eliminating the need for long-term implant presence and potentially reducing the risk of infection or graft-related complications.

3D Printing and Patient-Specific Grafts: 3D printing technology enables the creation of patient-specific grafts tailored to individual anatomical requirements. This customization improves the accuracy of graft placement and ensures optimal fit and functionality. Patient-specific grafts can be designed to match complex anatomies, making them particularly useful in treating aortic aneurysms with challenging geometries.

Advanced Imaging Techniques: High-resolution imaging techniques such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) play a crucial role in the diagnosis, planning, and post-operative evaluation of aortic and vascular graft procedures. These imaging modalities provide detailed visualization of the vasculature, aiding in precise graft sizing, placement, and surveillance.

Robotic-Assisted Surgery: Robotic-assisted surgical systems offer enhanced precision and dexterity to surgeons performing aortic and vascular graft procedures. These systems allow for smaller incisions, improved visualization, and greater maneuverability of surgical instruments. Robotic-assisted surgery can contribute to reduced trauma, faster recovery, and improved patient outcomes.

Nanotechnology: Nanotechnology has the potential to revolutionize aortic and vascular graft procedures. Nanomaterials, such as carbon nanotubes and nanofibers, can be incorporated into grafts to enhance their mechanical properties, promote cellular adhesion, and provide controlled drug release for targeted therapies. Nanotechnology-based approaches may lead to improved graft durability, reduced complications, and enhanced tissue regeneration.

For more insights on the North America Aortic and Vascular Graft Procedures market category analysis, download a free report sample

These emerging technologies and innovations in the North America Aortic and Vascular Graft Procedures market are driving advancements in the field, offering new treatment options, improving patient outcomes, and shaping the future of vascular surgery. Continued research and development in these areas hold the potential to further enhance the safety, efficacy, and long-term success of aortic and vascular graft procedures.

[anyawinget]

Vascular Grafts Market Size, Status and Growth Outlook 2022-2030

“The market crossed the US$ 3.49 billion mark in 2022 and is expected to hit US$ 6.41 billion by 2030, recording a CAGR of 7.92% during the forecast period.”

The report includes an executive summary, economic outlook, and overview sections which provide a consistent analysis of the Vascular Grafts Market. Additionally, the report in the Market overview section outlines PLC analysis and PESTLE analysis to provide a thorough analysis of the market. The overview section details Porter’s five forces analysis which helps to reveal a possible scenario of the market by disclosing a competitive scenario with respect to the Vascular Grafts Market.

To Get a Sample Copy of the Report, Click Here:

https://www.businessmarketinsights.com/sample/BMIRE00026877

The Vascular Grafts market following is the manufacturer’s cover-

Medtronic plc

Getinge AB

LeMaitre Vascular Inc

WL Gore and Assocaites, Inc

Cook Medical

CR Bard

Terumo Corporation

Shanghai Suokang Medical Implants Co. Ltd.

The leading players of the Vascular Grafts industry, their market share, product portfolio, and company profiles are covered in this report. Key market players are analyzed on the basis of production volume, gross margin, market value, and price structure. The competitive market scenario among Vascular Grafts players will help the industry aspirants in planning their strategies. The statistics presented in this report are an accurate and helpful guide to shaping your business growth.

Vascular Grafts Market Split by Product Type and Applications:

This report segments the Vascular Grafts Market on the basis of Types are:

Hemodialysis Access Grafts

Endovascular Stents Grafts

Peripheral Vascular Graft

On the basis of Application, the Vascular Grafts Market is segmented into:

Cardia Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Heart Disease

This analysis report also presents practical and practical case studies to help you get a clearer understanding of the subject. This analysis report has been prepared through industry analysis techniques and presented in a professional manner by including effective information graphics whenever necessary. It helps ensure business stability and rapid development to achieve notable remarks within the Vascular Grafts market.

Table of Content for Vascular Grafts Market Research Report:

Chapter 1: Industry Overview

Chapter 2: Vascular Grafts Market International and Regional Market Analysis

Chapter 3: Environment Analysis of Market.

Chapter 4: Analysis of Revenue by Classifications.

Chapter 5: Analysis of Revenue by Regions and Applications.

Chapter 6: Analysis of Vascular Grafts Market Revenue Market Status.

Chapter 7: Analysis of Industry Key Manufacturers

Chapter 8: Sales Price and Gross Margin Analysis of Market.

Chapter 9: ……………………. Continue to TOC

Finally, Vascular Grafts Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report provides locales, economic conditions, item values, benefits, limits, creations, supplies, requests, market development rates, and numbers, etc. Vascular Grafts industry report announces additional new task SWOT examination, and speculation achievement investigation and venture return investigation.

Click Here to Buy Now:

https://www.businessmarketinsights.com/buy/single/BMIRE00026877

Note: This report may be customized to suit your requirements. Get in touch with our sales team so you can get a report tailored to your needs.

About Us:

Business Market Insights is a market research platform that provides subscription services for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact Us:

If you have any questions about this report or would like further information, please contact us:

Contact person: Sameer Joshi

Phone: +16467917070

Email: sales@businessmarketinsights.com

Web URL: https://www.businessmarketinsights.com

[the-rachana]

Aortic Aneurysm Market Growth Elements, Recent Developments, and Key Players Strategy till 2031

The report extensively examines the global Aortic Aneurysm market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Aortic Aneurysm. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Aortic Aneurysm. We assist you with full and extensive research on the global Aortic Aneurysm Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Aortic Aneurysm.

Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/aortic-aneurysm-market/8565

Key Players Mentioned in the Global Aortic Aneurysm Market Research Report:

Medtronic plc

Gore Medical (W. L. Gore & Associates)

Endologix LLC

Cardinal Health Inc.

Terumo Corporation

Cook Medical Inc.

JOTEC (Cryolife Inc.)

MicroPort Scientific Corporation

Lombard Medical

Cardiatis S.A.

SEGMENTS

GLOBAL AORTIC ANEURYSM DEVICES MARKET - ANALYSIS & FORECAST, BY TYPE

Thoracic Aortic Aneurysm (TAA)

Abdominal Aortic Aneurysm (AAA)

GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY TREATMENT

Open Surgical Repair (OSR)

Endovascular Aneurysm Repair (EVAR)

GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY PRODUCTS

Stent Grafts

Catheters

GLOBAL AORTIC ANEURYSM MARKET - ANALYSIS & FORECAST, BY END USER

Hospitals

Ambulatory Surgery Centers

Clinic

Finding dominant companies in a specific Aortic Aneurysm industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Aortic Aneurysm research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Aortic Aneurysm, this study also examines important facets of each company's operations and presents market growth estimates.

Aortic Aneurysm Market TOC: https://www.growthplusreports.com/report/toc/aortic-aneurysm-market/8565

Aortic Aneurysm Market: Regional analysis includes

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/aortic-aneurysm-market/8565

Reasons to Buy This Report:

This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.

And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.

This record will help companions with greedy the global enterprise popularity and patterns of Aortic Aneurysm Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.

This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.

This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.

This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Aortic Aneurysm Administration Frameworks industry.

This record assists companions with obtaining bits of know-how into what locales to internationally target.

This file assists companions with obtaining experiences into the end-client perception regarding the reception of Aortic Aneurysm Administration Frameworks.

This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.

Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8565

Visit our report store at - https://www.growthplusreports.com/report-store

Manan Sethi

Director, Market Insights

Email: sales@growthplusreports.com

256 Chapman Road

STE 105-4, Newark,

New Castle - 19702, USA

Phone no: +1 888 550 5009

Web: https://www.growthplusreports.com/

About US

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."

[market-insider]

Vascular Grafts Market Boosted By Rising Number Of Chronic Kidney Diseases, Heart Attacks And Atherosclerotic Heart Diseases

The global vascular grafts market size is anticipated to reach USD 3.1 billion by 2030 and is expected to expand at a CAGR of 7.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.

Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

Gain deeper insights on the market and receive your free copy with TOC now @: Vascular Grafts Market Report

In 2021, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2021 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2021, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.     The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

[manideep8]

Abdominal Aortic Aneurysm Treatment Market Analysis - Forecast (2022 - 2027)

Abdominal Aortic Aneurysm Treatment Market size is estimated to reach $2.67 billion by 2027, growing at a CAGR of 5.82% during the forecast period 2022-2027. Abdominal aortic aneurysms are frequently discovered when a physical examination is performed for another reason or at the time of normal medical tests, like an ultrasound of the heart or abdomen. The objective of abdominal aortic aneurysm treatment is to avoid an aneurysm from breaking. Treatment may include cautious supervision or surgery. The kind of treatment adopted, relies on the size of the aortic aneurysm and how quickly it is developing. CT scan assesses the abdomen in more detail in patients with a particular abdominal grievance. It also evaluates the form of the aneurysm with more inclusive anatomical details of the mesenteric and iliac arteries, and also offers superior imaging of suprarenal aneurysms. Helical CT angiography can represent complexities that establish consequently to the treatment of abdominal aortic aneurysms with endovascular stent grafts. Long-term follow-up is needed to decide the complete spectrum and frequency of complexities that may establish after a favorable fix at the beginning. Conservation of spinal cord blood supply at the time of descending thoracic (TAA) and thoracoabdominal aortic aneurysm (TAAA) surgery is mandatory to avoid neurologic complexities. Investigations have been conducted to determine whether the preoperative and postoperative existence or absence of collateral arteries discovered by magnetic resonance angiography (MRA) is connected with spinal cord function at the time of the intraoperative exclusion of the segmental supply to the Adamkiewicz artery.

The increasing predominance of hypertension and hyperlipidemia is set to drive the Abdominal Aortic Aneurysm Treatment Market. The surging count of smokers with elderly male smokers requiring ultrasound screening along with pre-existing CT scans is set to propel the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027. This represents the Abdominal Aortic Aneurysm Treatment Industry Outlook.

Abdominal Aortic Aneurysm Treatment Market Report Coverage

The report: “Abdominal Aortic Aneurysm Treatment Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the  Abdominal Aortic Aneurysm Treatment Market.

By Treatment: Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR). By Product: Stent Graft, Catheter. By End Use: Hospital, Ambulatory Surgical Center, Others. By Geography: North America (U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=15315

Key Takeaways

Geographically, North America Abdominal Aortic Aneurysm Treatment Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of abdominal aortic aneurysm requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm in the North American region.

Abdominal Aortic Aneurysm Treatment Market growth is being driven by the rising pervasiveness of abdominal aortic aneurysm globally requiring abdominal and pelvic CT scans for deciding the size and extent of an aneurysm owing to altered lifestyle and the expanding population of the elderly. However, the cost and availability of treatment are some of the major factors hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.

Abdominal Aortic Aneurysm Treatment Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the   Abdominal Aortic Aneurysm Treatment Market report.

Request For Sample : https://www.industryarc.com/pdfdownload.php?id=15315

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Treatment:

The Abdominal Aortic Aneurysm Treatment Market based on treatment can be further segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). The Endovascular Aneurysm Repair (EVAR) Segment held the largest market share in 2021. This growth is owing to the enhanced patient survival offered by the Endovascular Aneurysm Repair technique. Endovascular repair (EVAR) is the positioning of a stent graft (fabric-covered tube) into the aneurysm by way of a tiny hole in the blood vessels in the groin. CT scan has been performed consequent to Endovascular Repair of Abdominal Aortic Aneurysms. The heightened demand for minimally invasive processes owing to minimized hospital stays and patient trauma in conjunction with the soaring success rate provided by technologically progressive devices is further propelling the growth of the Endovascular Aneurysm Repair (EVAR) segment.

Furthermore, the Open Surgical Repair (OSR) segment is estimated to grow with the fastest CAGR of 6.5% during the forecast period 2022-2027 owing to the superior outcomes of open surgical repair (OSR) in comparison with endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (IRAAA) as per results of a retrospective cohort investigation issued in the Journal Vascular Brasileiro and CT scan is recommended with or without contrast at 5-year intervals after open surgical repair for thoracic aortic disease.

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Product:

The Abdominal Aortic Aneurysm Treatment Market based on the product can be further segmented into Stent Graft and Catheter. The Stent Graft Segment held the largest market share in 2021. This growth is owing to the surging application of stent-grafts in Abdominal Aortic Aneurysm Treatment. Nellix and Ovation stent-grafts are novel generation prostheses that use polymer technology to treat abdominal aortic aneurysms. CT scan can be performed postoperatively. The benefits of endovascular repair with stent-graft are further propelling the growth of this segment.

Furthermore, the Catheter segment is estimated to grow with the fastest CAGR of 6.7% during the forecast period 2022-2027 owing to the surging application of Catheter-based aortic aneurysm repair attributed to it being a safe and preferred option of treatment for numerous patients with aortic aneurysms and investigations being conducted for intra-arterial catheter=directed CT angiography for evaluation of endovascular aortic aneurysm repair.

Abdominal Aortic Aneurysm Treatment Market Segment Analysis – By Geography:

The Abdominal Aortic Aneurysm Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Abdominal Aortic Aneurysm Treatment Market) held the largest share with 39% of the overall market in 2021. The growth of this region is owing to the increasing predominance of abdominal aortic aneurysms in the region. The continued technological upgrades in the healthcare sector and the increasing predominance of cardiovascular diseases requiring CT scans are further driving the growth of the Abdominal Aortic Aneurysm Treatment Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like expanding population of the elderly being more susceptible to incessant ailments requiring the application of CT scans in the Asia-Pacific region. The supportive government policies increased spending on healthcare, and proliferating modernization of medical infrastructure are further fuelling the progress of the   Abdominal Aortic Aneurysm Treatment Market in the Asia-Pacific region.

Abdominal Aortic Aneurysm Treatment Market Drivers

Surging Applications Of Abdominal Computed Tomography Angiography Are Projected To Drive The Growth Of   Abdominal Aortic Aneurysm Treatment Market:

Computed tomography angiography (CTA) transformed vascular imaging when vessels tinier than 1 mm in diameter were imaged with single-slice spiral CT. Other than its restricted invasiveness, the benefits of CT Angiography involve reduced cost and a possible minimization in the total volume of contrast material administered. With the quickest scanners presently accessible (16, 64, 256 slices), abdominal Computed Tomography Angiography may be carried out with as little as 50 mL of contrast material utilizing a saline flush. Typical abdominal uses of CTA involve assessment of the abdominal aorta, preoperative and postoperative evaluation for renal and liver transplantation, preoperative planning for hepatic segmentectomy and pancreatic surgery, mesenteric ischemia, and gastrointestinal (GI) hemorrhage. Additional uses involve cholecystectomy and splenectomy planning, and evaluation for renal arterial disease in the assessment of hypertension. The protocols for every use should be separately tailor-made to optimize imaging of the targeted vascular structures. CTA is typically the approved imaging modality for the assessment of the abdominal aorta in intense and non-emergent settings. The surging applications of abdominal computed tomography angiography are therefore fuelling the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.

Heightened Applications Of Magnetic Resonance Angiography For The Treatment of Infrarenal Abdominal Aortic Aneurysms Are Expected To Boost The Demand Of Abdominal Aortic Aneurysm Treatment Market:

Magnetic resonance angiography (MRA) like Computed Tomography Angiography (CTA) has the advantage of being able to envision the complete aorta inclusive of its branch vessels. Dissimilar to CTA, it does not reveal the patient to radiation nor is iodinated contrast dye needed. This can be more attractive for patients with a contrast allergy or renal inadequacy. In patients with kidney ailments, non-gadolinium contrast agents prevail. Blood pool contrast agents, like ferumoxytol, may be utilized to improve MRA to offer good imaging quality. Additionally, typical investigations have discovered that non-contrast magnetic resonance imaging (MRI), when teamed with electrocardiographic- and cardiac-gated methods, has identical image quality in comparison with contrast-enhanced MRA images of the aorta. Time-resolved 3D phase-contrast MRI with three-directional velocity encoding, also termed as 4D flow MRI has currently emerged as an instrument to more thoroughly assess abdominal circulation. 4D flow MRI may permit for more precise aortic modeling in the future owing to its capability to concurrently assess vascular anatomy and hemodynamics. MRA is commensurate to CTA with respect to the precision of AAA assessments. The heightened applications of Magnetic Resonance Angiography for the treatment of Infrarenal Abdominal Aortic Aneurysms are driving the growth of the Abdominal Aortic Aneurysm Treatment Market during the forecast period 2022-2027.

Abdominal Aortic Aneurysm Treatment Market Challenges

Handling Of The Ruptured Abdominal Aortic Aneurysm By Paramedics Poses Challenges To The Growth Of The Abdominal Aortic Aneurysm Treatment Market:

The ruptured abdominal aortic aneurysm is a time-critical medical emergency needing timely surgical intervention to provide any opportunity of survival. Even when identified early, 90% of patients will endure an out-of-hospital cardiac arrest prior to landing at the emergency department and of those who arrive at the theatre, only 40% will survive. The ruptured AAA needs urgent surgical intervention. These kinds of patients cannot be stabilized in the prehospital environment and endeavors to do so will be pointless and are likely to jeopardize patient care. The paramedic practitioners handling of the ruptured AAA must involve, and sometimes be restricted to, accelerated identification and practical transport to a hospital with competence in handling vascular emergencies. Intravascular access must not defer transport to a suitable receiving facility. Prehospital interventions like fluid administration can minimize the occurrence of post-operative complexities like acute renal failure. However, this should not be utilized to legitimize numerous cannulation efforts on the scene. The establishment of a fast-track pathway for direct admission to theatre could possibly save lives. Further research and the establishment of such a pathway should include all members of the multi-disciplinary team. These issues are hampering the growth of the Abdominal Aortic Aneurysm Treatment Market.

Buy Now : https://www.industryarc.com/purchasereport.php?id=15315

Abdominal Aortic Aneurysm Treatment Market - Landscape:

Product launches, mergers and acquisitions, joint ventures, and R&D Activities are key strategies adopted by players in the   Abdominal Aortic Aneurysm Treatment Market. Key companies of this market are:

Novartis Pharmaceuticals

Merck

Cook Medical Inc.

Endologix Inc.

W.L.Gore & Associates

Medtronic Plc.

Cardinal Health Inc.

Lombard Medical, Inc.

Terumo Aortic

Cardiatis S.A.

Recent Developments

In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to diminish the challenges of medicine non-adherence. Outcomes convey digital health solutions for personalized medication therapy administration, digital patient engagement, and tele pharmacy, through its Connect™ platform. Therefore, these three customer groups can enhance patient adherence to medicine, fuel superior health outcomes for patients, and reduce the cost of care.

In July 2020, Novartis declared a novel initiative to assist patients in low-income and lower-middle-income countries (LIC; LMIC) access economical medications to treat the principal symptoms of COVID-19 – a crucial requirement in the absence of a vaccine or curative treatment. Inflammation and respiratory issues connected with COVID-19 may bring about serious medical complexities and may result in demise in certain people, establishing an enormous burden on delicate healthcare systems. The Novartis COVID-19 portfolio involves 15 medications from its Sandoz division for gastrointestinal sickness, intense respiratory symptoms, pneumonia, and septic shock.

In March 2020, Endologix® Inc. declared that it has accepted an endorsement from the U.S. Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto). The firm accepted endorsement based on its supervisory compliance that involves the ELEVATE Investigational Device Exemption (IDE) clinical investigation. Agreeable to the terms of endorsement, the earliest 100 patients consequent to commercial introduction will be involved in a post-approval imaging study to decide constancy in instrument choice between Endologix’s internal imaging services and those of the implanting physicians.

Related Reports-

Endovascular Abdominal Aortic Aneurysm Repair Devices Market

Report Code: HCR 46793

Aortic Aneurysm Market

Report Code: HCR 81184

For more Lifescience and Healthcare related reports, please

click here

[bloggerthrive]

Global Abdominal Aortic Aneurysm Repair Devices Market Outlook

The growth of a section of the aorta, the body's main blood vessel, which passes through the abdomen, is referred to as a "abdominal aortic aneurysm." Men experience AAA more frequently than women do, and it affects those over 50. Other factors including smoking and high blood pressure can also contribute to AAA. Surgical intervention was once used to treat AAA; endovascular stent grafting has since taken its place. Abdominal Aortic Aneurysm Repair Devices Market stent grafting is a minimally invasive procedure that has several benefits over open surgery, such as less blood loss, quicker recovery times, shorter stays in the hospital, and lower mortality and morbidity.

Read More:

https://knackersblogger.blogspot.com/2022/09/north-america-is-expected-to-hold.html

[meditech-insights]

Global Endovascular Devices Market valued at US$ 5.4 bn in 2021 and is anticipated to grow at a CAGR of 5% By 2026

Endovascular surgery is an advanced procedure that is performed using minimally invasive catheter techniques on the arteries or veins. Procedures include aneurysm repair, cardiovascular disorders, peripheral vascular diseases, renal vascular diseases, deep vein thrombosis (DVT), varicose vein repair, stroke, among others. A wide variety of guidewires, catheters, crossing devices, balloons, stents, atherectomy devices, drug-coated devices, and other devices are used for endovascular treatment.

The Global Endovascular Devices Market valued at US$ 5.4 bn (2021) is projected to witness a growth rate of 5% in the next five years. Rising preference for endovascular aneurysm repair (EVAR) procedures, technological advancements in endovascular devices, the increasing geriatric population & corresponding rise in the prevalence of cardiovascular diseases, lifestyle factors (diet, exercise), ease & availability of endovascular procedures, and favorable reimbursements for endovascular procedures are some of the key factors driving the global Endovascular devices market. 

Cumulative Preference for Endovascular Aneurysm Repair (EVAR) Procedure Opens Growth Opportunities for Endovascular Devices Market

An aortic aneurysm is a bulge that occurs in the wall of the aorta that carries blood from the heart to the body. It increases the risk of developing a tear in the inner layer of the wall of the aorta. An aortic aneurysm can be abdominal or thoracic. An abdominal aortic aneurysm (AAA) occurs when a portion of the abdominal aorta bulges into an aneurysm because of a weakening of the vessel wall. AAA may result in life-threatening internal bleeding upon rupture and hence patients diagnosed with AAA are treated with open surgical repair or mostly via less invasive endovascular aneurysm repair (EVAR). During the EVAR procedure, a stent graft is inserted into the aorta which protects the aorta from tearing. 

The EVAR is widely accepted as a standard of care for aortic aneurysms & supported by vascular surgeons due to the following benefits:

Shorter stay in the hospital.

Relatively less blood loss

Faster return to routine activities

Shorter procedure time as compared to open surgery, among others

Citing the lucrative prospects of EVAR technology, companies are launching innovative products in new markets. 

For instance,

In May 2021, Endologix launched Alto® Abdominal Stent Graft System in Canada and Argentina. The launch boots the company’s global reach with the latest endovascular aneurysm repair (EVAR) technology

“Endovascular aneurysm repair (EVAR) has emerged as a safe, and effective method of treating abdominal aortic aneurysms as it lowers the risk of life-threatening tears & ruptures. Technological advancements in EVAR have not only allowed vascular surgeons to achieve therapeutic aims but also reduced procedural risks and patient discomfort." - Director, Leading Endovascular Device Manufacturer, United States

Explore Premium Report on Endovascular Devices Market @ https://meditechinsights.com/endovascular-devices-market/

Technological Advancements Drive the Global Endovascular Devices Market

The endovascular devices market is a technology-driven market and is marked by product enhancements/innovations. 

For instance,

In June 2022, Medtronic India launched a fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms

Organic and Inorganic Advance Strategies Adopted by Players to Establish Their Position in Endovascular Devices Market

The endovascular devices market is marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as acquisitions, and new product launches to garner market share. 

For instance,

In March 2022, Cook Medical received FDA Breakthrough Device Designation for Zenith® Thoraco+ Endovascular System. The Thoraco+ is built on the strength of the proven Zenith platform and represents a next-generation endovascular graft for the treatment of thoracoabdominal aortic aneurysms. The system is indicated for the endovascular treatment of patients with thoracoabdominal aortic aneurysm

The endovascular devices market is expected to continue to grow in the coming years due to growing cases of peripheral, aortic, & venous diseases, an increase in the smoking population, growth opportunities in the APAC region, technological advancements in endovascular devices, and favorable reimbursement in key markets.

Competitive Landscape Analysis of Endovascular Devices Market

The global endovascular devices market is marked by the presence of players such as Cordis, Medtronic, Boston Scientific, Cook Medical, Abbott, Gore Medical, Cardiovascular Systems, Inc. (CSI), Terumo, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[marketresearchlatestreports]

Branched Stent Grafts Market: Key Players to Gain Competitive Advantage

The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.

ResearchMoz report delivers an in-depth analysis of the global stent grafts interface marketplace, including its size, key drivers for growth, major opportunities and challenges it faces along with the regional segments that will experience significant expansion over time.

Polymer-Based Technology to Drive the Branched Stent Grafts Market

Recently, polymer-based technologies have been recommended as an alternative to fix abdominal aortic aneurysms (AAA). There are two categories under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin neoprene-based neck sealing device that’s also called the Ovation stent graft. EVAS was not successful despite being in use for some time now but EVAR has established itself as safe and effective; leading to the expansion of the global branched stents market.

Growing Vascular Surgeries Boost Demand

The growing number of vascular surgeries are driving the global branched stent grafts market and will continue during the forecast period. This is primarily due to the growing geriatric population across the globe and growing cases of coronary heart diseases.

However, the poor durability of metallic grafts will impede the growth during the forecast period.

Nonetheless, the rising demand for biocompatible stents will allow the market to grow exponentially in the coming years.

The players in the global branched stent-grafts market include-

Abbott

Cook Medical

Eucatech AG

Merit Medical Systems

Endocor GmbH

Boston Scientific Corp.

Terumo Corp.

Medtronic

Biotronik

Alvimedica

Cardinal Health (Cordis)

Read More: https://www.beetribune.com/branched-stent-grafts-market-survey-report/

Key takeaways

ReseachMoz shares detailed insights on the branched stent grafts market, which will help the stakeholders to be informed and take thoughtful decisions to thrive in this space. Some of the key takeaways from the report.

The global branched stent grafts market will exhibit growth at 8.0% CAGR between 2021 to 2028.

The increasing prevalence of coronary artery diseases and the rising number of geriatric populations are driving this market.

Asia-Pacific holds a promising future as well for branched stent grafts due to its high incidence rates of coronary heart diseases. While North America will dominate the global branched stent market in the coming years.

Regional Outlook

 North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Russia

Greece

The Netherlands

Asia Pacific

Japan

China

India

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Download Report PDF: Branched Stent Grafts Market

[fmihealthcare-blog]

Endovascular Therapy Devices Market is expected to register a healthy CAGR during the forecast period.

Endovascular therapy Devices: Market Insights

A procedure involving endovascular therapy devices are used to insert a flexible, sterile plastic tube, stents or a catheter into a blood vessel to allow blood to be withdrawn from or medication to be delivered to a patient’s bloodstream over a period of time. These endovascular therapy devices can be used either for intravenous antibiotic treatment, chemotherapy, long-term intravenous feeding and blood transfusions. The market is challenged by many medical complexities requiring cardiovascular disease treatment from inside the blood vessel, strokes and other cardiovascular conditions. The market of endovascular therapy devices contains products which are less invasive, requiring patients to spend less time in the hospital, less recovery time and devices which cause less pain. The endovascular therapy devices market is dominated by minimally invasive, catheter-based procedure. These procedures are often performed in a cardiac catheterization labs present in hospitals.

Endovascular therapy Devices: Market Dynamics

The global endovascular therapy devices market will increase in forecast period 2018-28. Endovascular therapy devices market will be driven primarily by the rise in incidence of cardiovascular patients, economic power in some regions leading to lifestyle change, growing disposable income and, increasing expenditure. In addition, recent developments in stent technology and increased experience of interventionists will propel the growth of the global endovascular therapy devices market in the future. However, high cost involved in usage of new endovascular therapy devices, less awareness in economically poor nations, and US’s stringent tax regulation rules on medical devices are expected to be some of the major restraints in global market for endovascular therapy devices market. 

Request Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-7693

Endovascular therapy Devices Market: Segmentation

Segmentation by Product Type:

Percutaneous endovascular aneurysm repair (EVAR)

Fenestrated EVAR

Aortic stents

Biodegradable Stents

Self-expanding Nitinol Stents

Thoracic aortic aneurysms grafts

Other Devices

Segmentation by Procedures:

Balloon Angioplasty

Angioplasty with Stent Placement

Drug-Eluting Stents (DES)

Renal Artery Angioplasty and Stenting

Carotid Artery Stenting

Transfemoral Carotid Artery Stenting

Transcarotid Artery Revascularization

Intravascular Brachytherapy

Atherectomy

Thrombolysis

Segmentation by Application

Pulmonary

Vascular

Cardiology

Surgery

Neurology

Radiology

Segmentation by End User Type:

Hospitals

Clinics

Research Institutes

Endovascular therapy Devices Market: Overview

The endovascular therapy devices market has grown exponentially since its inception in the early 1990s. Global estimates for the market reflects several factors. The use of manual compression has significantly lowered down in obese patients or patients on anticoagulation. However, complex procedures performed with a percutaneous endovascular therapy devices have taken strides as they offer bigger sheath sizes. As the economic landscape of health care becomes more competitive, endovascular therapy devices are becoming increasingly valuable because it frees up time for other work. Current market trends are focused on developing endovascular therapy devices that can be safe and efficient enough to close large-caliber femoral arteriotomies. As transcatheter aortic valve repair and percutaneous endovascular aneurysm repair are increasing in popularity, there will be tremendous opportunity for the manufacturers in the market to develop and manufacture simple but effective endovascular therapy devices in future..

Endovascular therapy Devices Market: Region-wise Outlook

Globally, global Endovascular therapy Devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East.  North America will account for the largest share in global Endovascular therapy Devices market. Besides the region’s Endovascular therapy Devices market growth will also increase due to obesity and diet, and new products lunch due to presence of leading manufacturers in the region. Europe with robust healthcare infrastructure, will drive the endovascular therapy devices market in this region. Technological advances in the region in the past decade have shifted revascularization strategies from traditional open surgical approaches. Focus has shifted towards lower-morbidity percutaneous endovascular treatments for patients with peripheral arterial disease.  Asia Pacific mainly including India, China, AUS&NZ and Latin American countries are expected to be a significant market contributors in the rising Endovascular therapy Devices market.  Advancements in stent designs by leading and local manufacturers in the region have fueled the growth of endovascular therapy devices in the region due liberalization of healthcare polices and trade related implications.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7693

Endovascular therapy Devices Market: Key Players

Some of the key players present in global Endovascular therapy Devices market include Cardinal Health, Altura Medical, Lifetech Scientific BiFlow Medical, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline,  Lombard Medical Technologies, Endologix, Medtronic, Nellix, Penumbra and Terumo. In addition presence of small and local manufacturers across the countries will account for competiveness in Endovascular therapy Devices market.

[jainm24]

Thoracic Stent Graft Market  Share, Industry Growth, Trend, Key Companies by 2028

The Global thoracic aortic stent-graft complications Market report published by Reports and Data is a concise summary on the thoracic aortic stent-graft complications industry and offers deep insights into the industry’s core structure and mechanism. The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry’s leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics. Market insights included in the report have been compiled through extensive research, detailed market surveys, and expert interviews.

Key market dynamics illustrated in the report include market share, market size, revenue growth drivers, restraints, opportunities, threats, challenges, emerging market trends, product innovations, and industry revenue growth rate. Other imperative factors highlighted in the report are volatility in demand and supply graphs, production & consumption patterns, paradigm shifts in consumer preferences, import/export analysis, and a multitude of macro-economic and micro-economic growth indicators. Going ahead, the report elaborates on the highly competitive environment of the thoracic aortic stent-graft complications industry and discusses the strategic initiatives undertaken by each market player, including partnerships & collaborations, mergers & acquisitions, joint ventures, government & corporate deals, and new product launches.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4474

Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Top Players in the Global thoracic aortic stent-graft complications Market:

Abbott Laboratories

Lombard Medical

Cordis Corporation

Terumo Corporation

Boston Scientific

MicroPort Scientific Corporation

Medtronic

Biosensors

Lifetech Scientific

Medtronic Plc

Evasc Medical Systems Corp.

Endologix

L.Gore & Associates, Inc.

TriVascular, Inc.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/thoracic-stent-graft-market

thoracic aortic stent-graft complications Market Segmentation:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

Hemodialysis Access Graft

Endovascular Stent Graft

Peripheral vascular

Others

Application Outlook (Revenue, USD Billion; 2018-2028)

Cardiovascular Diseases

Cardiac Aneurysm

Kidney Failure

Others

Global thoracic aortic stent-graft complications Market Report: Regional Segmentation

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4474

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.